Nasent mRNA chains are capped at the 5' end by the addiion ofa guanylyl residue to form a G(5')ppp (5' 
Capping of eukaryotic pre-mRNA is the earliest detectable RNA processing event (1, 2) . The cap consists of an inverted 7-methylguanosine residue linked via a 5'-5' triphosphate bridge to the first transcribed residue. Capping proceeds by the sequential action of several enzymatic activities (reviewed in refs. 3 and 4) . Nascent RNA molecules synthesized by RNA polymerase II carry 5'-triphosphate termini. The capping enzyme possesses a RNA 5'-triphosphatase activity that removes the terminal phosphate and a guanylyltransferase (GTP:mRNA guanylyltransferase, EC 2.7.7.50) activity that catalyzes the transfer of a GMP moiety from GTP to the 5'-diphosphoryl group of the RNA. Subsequent methylation of the cap (5-7) may serve to prevent reversal of the guanylyl transfer reaction (8) . These reactions may be summarized as follows:
'Yta Interest in the mechanism of capping has focused attention on the E-GMP complex. Cellular mRNA guanylyltransferases from human, rat liver, calf thymus, Artemia salina, wheat germ, and Saccharomyces cerevisiae all form E-GMP covalent complexes (reviewed in ref. 3 ). In addition, cytoplasmic viruses encode their own capping enzymes. The guanylyltransferases of vaccinia virus (12, 13) , reovirus (11, 14, 15) , African swine fever virus (16) , rotavirus (17) , bluetongue virus (18) , and Shope fibroma virus (19) have also been shown to form E-GMP complexes. The E-GMP complex has been shown to act as a bonafide intermediate in the transguanylation reaction (10, 11) . The nucleotidyl attachment site is a lysine in the rat liver (13) , reovirus (20) , and vaccinia virus guanylyltransferases (13, 21) . The nucleotidylenzyme linkage is a phosphoamide bond between the catalytic lysine and GMP (10, 12-14, 21, 22) , suggesting that the nucleotidyl transfer mechanism proceeds via nucleophilic attack of the E-amino group of the lysine on the a phosphate of GTP (23) . The extensive conservation of the capping reaction suggests that the GMP-lysine bond is a feature of all guanylyltransferases.
The S. cerevisiae capping enzyme is a heterodimer of 80-kDa and 52-kDa subunits possessing 5'-triphosphatase and guanylyltransferase activities, respectively (24, 25) . The essential gene CEGI encodes the small subunit (26) (16, 28) . In contrast, the guanylyltransferase active site from reovirus (20) does not obviously conform to this consensus. While no extensive sequence similarities to the viral capping enzymes are apparent, the guanylyltransferase of S. cerevisiae contains a short sequence that is similar to the proposed consensus motif for nucleotidyl attachment (16, 28) .
To determine the guanylylated residue of the yeast capping enzyme, we performed phosphopeptide sequencing and examined the effects ofreplacement ofthe suspected active-site lysine. We report here that the site of guanylyl attachment in yeast CEG1 is Lys-70. The active-site sequence conforms to a motif for nucleotidyl attachment found in enzymes that catalyze nucleotidyl transfer to nucleic acid substrates.
MATERIALS AND METHODS
Plasmids. The CEGI gene was amplified from S. cerevisiae genomic DNA by the polymerase chain reaction (PCR) using oligonucleotide primers derived from the published genomic sequence (26) . The entire CEGI gene was amplified by using oligonucleotide primers CEG1-A5' and CEG1-C3'. The CEG1 open reading frame (ORF) was amplified by using primers CEG1-B25' and CEG1-C3', creating an Nco I site at the initiation codon in the process. The sequences of PCR primers are as follows: CEG1-A5', 5'-GGGAGATCTCAC-TGAAAGGCAGATGATC-3'; CEG1-B25', 5'-GGGAGAT-CTGCCATGGTTTTAGCAATGGAAAGTAGAG-3'; and CEG1-C3', 5'-GGGAGATCTATAACACTTTCACCCTC-GCTTCTC-3'.
The PCR product containing the entire CEGI gene was digested with Bgl II and ligated into the BamHI site of pRS315, pRS316 (29) , or pBSKS(+), generating pRS315-CEG1, pRS316-CEG1, and pBSKS(+)-CEG1, respectively. The PCR product containing the CEGI ORF was digested with Bgl II and inserted into the BamHI site of pBSKS(+) to create plasmid pBSKS(+)-CEGlorf.
For bacterial production of CEG1 protein and to facilitate purification by Ni2+ chelate chromatography, the ORF was cloned downstream of a phage 17 promoter and engineered to carry seven histidine residues at the N terminus. The Nco I-HindIll CEGI ORE fragment from pBSKS(+)-CEGlorf was cloned into the Nco I and HindIII sites of pETlld-His7 to create pETl1-HisCEGlorf. For expression of CEGI mutants encoding a replacement for Lys-70, the 1.1-kb EcoRI fragments from pRS315-CEG1 mutant plasmids carrying the Lys-70 mutation (see below) were inserted into EcoRIcleaved pET11-HisCEGlorf. Plasmid sequences were venfied by DNA sequencing with dideoxynucleotides (Sequenase 2.0; United States Biochemical).
A CEGI disruption allele was constructed as follows: a 1.6-kb Pst I-Spe I CEG) fragment from pBSKS(+)-CEG1 was inserted into the Pst I and Spe I sites of pBSKS(+) from which the polylinker sequences between the EcoRI and Xho I sites were deleted. The resulting plasmid [pBSKS(+)(ARI-X)-CEG1] was digested with EcoRI and Xho I, removing the region encoding amino acids 36 through 397. A 2.4-kb EcoRISal I fragment carrying the HIS3 gene was inserted into the plasmid, generating pBSKS(+)(AR-X)-ceglAl::HIS3.
Mutant alleles of CEGI were created by oligonucleotidedirected mutagenesis as described (30) . pRS315-CEG1 was used to transform the dur ung-Escherichia coli strain CJ236, and uracil-containing single-stranded phagemid DNA was isolated following infection with M13K07 helper phage. Mutagenic oligonucleotides were phosphorylated by using T4 polynucleotide kinase and annealed to the phagemid DNA, and extension and ligation reactions were performed as described (30) . E. coli strain S28 (dut+ ung+) was transformed with the reaction products to select against the uracil-containing parental strand. Plasmid DNA was isolated by alkaline lysis miniprep procedure, and mutants were identified by DNA sequencing.
The sequences ofthe mutagenic oligonucleotides, designed to change the amino acids at Lys-59 and Lys-70 are as follows: CEG1-K59mutS', 5'-CTGATGTGGAAGAGABBC-TGCTTGCGCATG-3', where B = T, C, or G; and CEG1-K70mutS', 5'-GATTACTACGTTTGTGAGABNACAGA-TGGTCTGCGGG-3', where N = T, C, G, or A.
Yeast Methods. Plasmids were introduced into yeast by using a modified lithium acetate transformation protocol (31) . Media preparation, tetrad dissection, genomic DNA isolation, plasmid shuffling, and all other yeast manipulations were performed by standard methods (30, 32) . 5-Fluoroorotic acid (5-FOA) was purchased from PCR Incorporated.
Yeast Srains. Yeast strains were CTY143 (MATa/MATa ura3-52/ura3-52 leu2-3,112/leu2-3,112 his3A200/his3A20OX), YSB225 (MATa/MATa ura3-52/ura3-52 leu2-3,112/leu2-3, 112 his3A200/his3A200 CEGJ/cegll ::HIS3), YSB238 (MATa/MATa ura3-52/ura3-52 leu2-3,112/leu2-3,112 his-3A2700/his3A200 CEGI/ceglAl::HIS3 {pRS316-CEG1}), and YSB244, (MATa ura3-52 leu2-3,112 his3A2X00 ceglAl::HIS3 {pRS316-CEG1}).
CTY143 was transformed with Pst I/Sma I-digested pBSKS(+)(ARI-X)-ceglAl::HIS3. His+ transformants were selected after [3] [4] [5] [6] Prifcation of Recombinant Guanylyltransferase. Polyhistidine-tagged CEG1 (His7-CEG1) proteins were expressed by using a 17 promoter/polymerase system in E. coli strain pGP1-2/K38 (33) . Strains carrying bacterial expression plasmids were grown at 300C to an OD595 =0. 5 (34, 35) . A control reaction lacking His7-CEG1 was electrophoresed in an adjacent lane for comparison. The guanylylated peptide was localized by autoradiography, cut out of the gel, eluted in 500 jd of distilled water, and spotted onto Immobilon-N (Millipore) membrane as described (34) .
After washing with 50%6 methanol, the radioactive spots were cut out, and the attached peptide was sequenced with an Applied Biosystems model 475 microsequencer.
RESULTS
Idenficat ion of the CEG1 Active Site by Phosphopeptide Sequencing. To identify the active-site lysine in CEG1, His7-CEG1 protein was produced and purified from E. coli crude extract by Ni2+ chelate and Mono S FPLC (Pharmacia) chromatography. His7-CEG1 protein was radioactively labeled by guanylylation with [a-32P]GTP. The E-GMP complex was then digested to completion with the sequencespecific protease trypsin. The labeled GMP-peptide was purified by alkaline 40o acrylamide gel electrophoresis (Fig.  1A) , spotted onto a positively charged membrane (Immobion N), and microsequenced directly (34, 35) .
The partial sequence obtained from the peptide was Xaa-(Leu or Phe)-Ala-His-(Asp or Leu)-Tyr-(Tyr or Val)-Val-, where Xaa signifies an unidentified residue (Fig. 1B) . Sequence further into the peptide was not interpretable. The obtained sequence of the guanylylated peptide matches residues 60-67 of CEG1. Since trypsin cleaves after the basic amino acid residues lysine and arginine, the guanylylated peptide must include amino acids 60-70 (Fig. 1B) . In addition, the peptide would extend to amino acid 75 if the attached nucleotidyl group blocked cleavage by trypsin, as previously observed for the ligase-AMP intermediates (36, 37) . The GMP residue is linked to CEG1 by a phosphoamide bond (13) . Therefore, the guanylylated residue is predicted to be either His-63 or Lys-70, since these are the only amino acids in the peptide capable of forming a phosphoamide bond. To date, all of the characterized nucleotidyl attachment sites of guanylyltransferases and polynucleotide ligases are lysine residues. Furthermore, the S. cerevisiae Lys-70 is conserved in the Schizosaccharomyces pombe guanylyltransferase, while His-63 is not (see below). For these reasons, we believe that Lys-70 must be the guanylyl attachment site in CEG1.
Replacements of Lys-70 Abolish CEG1 Activity in Vivo. To confirm that Lys-70 is the site of guanylylation, mutant alleles substituted at this position were assayed for the ability to support viability in vivo by plasmid shuffling (Fig. 2) . As a control, proteins containing substitutions for the nearby Lys-59 were also tested. CEGJ alleles carried on the LEU2 plasmid pRS315, or pRS315 alone (vector), were used to transform YSB244, a haploid yeast that harbors WT CEG1 on a URA3 plasmid (pRS316-CEG1), which complements the chromosomal CEG) null allele. His+ Leu+ transformants were purified and replica-plated to medium containing 5-FOA to select against cells that retained the URA3 plasmid. Strains Proc. Nad. Acad Sci. USA 91 (1994) ra59 ' "',q9
containing either the WT gene or mutant gene carrying a replacement for Lys-59 (Lys-59 --Thr, Ser, or Arg) fully complemented the CEGI null allele. In contrast, strains that harbor the pRS315 vector or replacements for Lys-70 (Lys-70 -* Met, Ile, or Thr) were inviable. Even the conservative replacement of lysine by arginine abolished CEGI function in vivo.
Substituions at Lys-70 Abrogate Guanylylation in Vitro. Substitutions of the active-site lysine abolish nucleotidylenzyme complex formation in vaccinia virus guanylyltransferase and DNA ligase (28) , T4 RNA ligase (38) , and human DNA ligase I (39) . We tested the ability of recombinant HisrCEG1 proteins substituted at Lys-70 to be guanylylated in vitro. E. coli extracts containing WT His7-CEG1 or proteins substituted at position 70 with isoleucine or threonine, as well as a control extract, were passed through Ni2+-NTAagarose. The partially purified proteins were resolved by gel electrophoresis and visualized by Coomassie blue staining (Fig. 3A, lanes 3-5) . Purified HisrCEG1 was used as a size standard (lane 2). The mutant proteins were produced at levels equal to the WT protein, suggesting that the amino acid substitutions did not cause gross disturbances in folding or stability in vivo. The proteins were assayed for E-GMP complex formation by using [a-32P]GTP (Fig. 3B) . In contrast to the WT protein (lanes 4 and 8), guanylylation ofthe mutant CEG1 proteins was undetectable (lanes 9 and 10) even upon longer exposure of the gel (data not shown). As expected, no activity was evident in the control extract (ane 7). Therefore, Lys-70 is essential for guanylylation of the S. cerevisiae capping enzyme in vitro. (13, 20, 21) . Also, in the guanylyltransferase of Sch. pombe, the position corresponding to Lys-70 is conserved (see Fig. 4 ). Furthermore, the sequence surrounding Lys-70 conforms to a motif that appears to be conserved in a family of nucleotidyltransferases (see below). Therefore, biochemical, genetic, and evolutionary data all indicate that Lys-70 is the active-site residue of the S. cerevisiae mRNA-capping enzyme guanylyltransferase.
DISCUSSION
As pointed out by Cong and Shuman (28) and by Pena et al (16) , sequences around the known and putative active sites of mRNA guanylyltransferases exhibit a short stretch of . 27; see Fig. 4 ). The sequence Lys-Xaa-Asx-Gly is conserved without exception in both families of enzymes. In the guanylyltransferases, several other positions are at least partially conserved. The residue following the active-site lysine is usually a threonine or a serine, while tyrosine or phenylalanine appears four residues upstream. Several other positions near this motif appear to favor hydrophobic residues. Only the reovirus guanylyltransferase diverges significantly, although its active site may be aligned with the consensus sequence by allowing the insertion of an extra amino acid position into the core motif (see Fig. 4 ).
Sequence similarity between the active sites of guanylyltransferases and polynucleotide ligases suggests that a common catalytic mechanism is employed in the capping and ligation reactions. Formation of phosphodiester bonds by ligases proceeds by nucleophilic attack of the active-site lysine on ATP (or NAD+) with formation of a covalent enzyme-adenylyl (E-AMP) intermediate and release of pyrophosphate (or NMN). The activated adenylyl moiety is transferred to the phosphate residue at the 5' end of the first substrate nucleic acid strand, activating it for attack by the ribose 3'-OH from the second substrate polynucleotide. Thus, the AMP is released as the polynucleotides are joined (reviewed in ref. 27 ).
The nucleotidyl transfer mechanisms of guanylyltransferases and ATP-or NAD+-dependent DNA and RNA ligases are similar in the following respects: (i) covalent phosphoamide intermediates are formed between the E-amino group of lysine and the 5'-phosphate of a nucleotide, (ii) the transferred mononucleotides are purines. (iii) the nucleotidyl acceptor molecules are polynucleotides with 5' phosphates, (iv) transfer of the mononucleotides to the substrates generates 5',5'-phosphoric anhydride bridge structures (GpppN... orAppN. . .), and (v) divalent cations Mg2+ or Mn2+ are required for activity.
The parallels between the capping and ligation reactions suggest that the similarities in active-site sequences represent true homology. The motif proposed for nucleotidyl attachment in the DNA and RNA ligases can be extended to include guanylyltransferases. One can only speculate whether these sequence similarities represent divergent evolution from an ancestral nucleotidyl transferase or convergent evolution due to constraints on active-site structure imposed by the chemistry of nucleotidyl transfer.
